Resource centre

Main menu

354 results

Structural variation

Poster
Poster: structural and epigenetic profiling of D4Z4 arrays in FSHD using Oxford Nanopore sequencing
March 9 2026
Publication
Concurrent L1 retrotransposition events promote reciprocal translocations in human tumorigenesis
February 26 2026
Publication
Flexible and rapid validation of structural variation using adaptive sampling
February 23 2026
Publication
Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications
February 11 2026
Publication
Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy
January 16 2026
Publication
Long-read genome sequencing enhances diagnostics of paediatric neurological disorders
January 9 2026
Publication
Oxford Nanopore Technologies [ONT] sequencing: clinical validation in genetically heterogeneous disorders
November 3 2025
Publication
Pre-phasing long reads improves structural variant genotyping
October 24 2025
Publication
Nanopore long-read sequencing for the critically ill facilitates ultrarapid diagnostics and urgent clinical decision-making
October 20 2025
Publication
Long-read genome sequencing and multi-omics in ageing and neurodegeneration
October 15 2025
Poster
Resolving challenging medically-relevant genes using nanopore sequencing
October 14 2025
Publication
Single-workflow nanopore whole-genome sequencing with adaptive sampling for accelerated and comprehensive paediatric cancer profiling
October 3 2025
Case study
Testimonial: Yaw Bediako
September 30 2025
Publication
Integrating long-read nanopore sequencing for precision resolution of genomic variants in dystonia
September 30 2025
Publication
Rapid epigenomic classification of acute leukaemia
September 22 2025
Publication
Deep intronic SVA_E insertion identified as the most common pathogenic variant associated with Canavan disease: a diagnostic blind spot
September 22 2025
Publication
A complete diploid human genome benchmark for personalised genomics
September 21 2025
Workflow
Workflow overview: 24-hour human whole-genome sequencing
September 17 2025
Getting started guide
Getting started guide: human genomics
September 17 2025
Application note
Application note: Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel
September 16 2025

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Focus areas

Resource Centre

Poster: structural and epigenetic profiling of D4Z4 arrays in FSHD using Oxford Nanopore sequencing

Concurrent L1 retrotransposition events promote reciprocal translocations in human tumorigenesis

Flexible and rapid validation of structural variation using adaptive sampling

Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications

Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy

Long-read genome sequencing enhances diagnostics of paediatric neurological disorders

Oxford Nanopore Technologies [ONT] sequencing: clinical validation in genetically heterogeneous disorders

Pre-phasing long reads improves structural variant genotyping

Nanopore long-read sequencing for the critically ill facilitates ultrarapid diagnostics and urgent clinical decision-making

Long-read genome sequencing and multi-omics in ageing and neurodegeneration

Resolving challenging medically-relevant genes using nanopore sequencing

Single-workflow nanopore whole-genome sequencing with adaptive sampling for accelerated and comprehensive paediatric cancer profiling

Testimonial: Yaw Bediako

Integrating long-read nanopore sequencing for precision resolution of genomic variants in dystonia

Rapid epigenomic classification of acute leukaemia

Deep intronic SVA_E insertion identified as the most common pathogenic variant associated with Canavan disease: a diagnostic blind spot

A complete diploid human genome benchmark for personalised genomics

Workflow overview: 24-hour human whole-genome sequencing

Getting started guide: human genomics

Application note: Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel

Filter

Products

Research areas

Techniques